e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug-susceptibility testing in tuberculosis: methods and reliability of results
Kim S. J.
Source:
Eur Respir J 2005; 25: 564-569
Journal Issue:
March
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kim S. J.. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 2005; 25: 564-569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
GenoType MTBDRsl performance on clinical samples with diverse genetic background},
Source: Eur Respir J 2012; 40: 690-698
Year: 2012
Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Source: Eur Respir J 2008; 32: 1165-1174
Year: 2008
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Results of multicentral external quality assessment for
M. tuberculosis
drug susceptibility testing in Russia
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005
The quantiferon testing and the diagnosis of tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Rapid genotypic assays for detection the rifampin and isoniazid resistance in
M. tuberculosis
strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Comparison of genotype MTBDRplus assay for rapid detection of rifampicin and isoniazid resistance with conventional drug susceptibility tests in a tertiary care hospital in India
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019
Year: 2019
Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay
Source: Eur Respir J 2013; 41: 1163-1171
Year: 2013
IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept